EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma

Mickey Konings, Emmanuel Siddig, Kimberly Eadie, Carole Pab Minlekib, Maguette Faye, Doudou Sow, Ahmed Fahal, Annelies Verbon, Wendy van de Sande

European Journal of Clinical Microbiology & Infectious Diseases · 2025-07 · 44 (7) · 1705-1714

DOI: 10.1007/s10096-025-05134-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 30.04.2025. Verfasst von Mickey Konings und 8 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus MC, Department of Medical Microbiology and Infectious Diseases, University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam, 3015GD…. Hauptthemen laut MEDLINE: Mycetoma, Multiplex Polymerase Chain Reaction, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diorapthe Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Mycetoma is a neglected tropical disease that affects the subcutaneous tissue. The disease can be caused by over 90 different pathogens, including both bacteria (actinomycetoma) and fungi (eumycetoma). While diagnostic tools for eumycetoma causative agents are available, these are generally not well suited for use in endemic regions. This study aims to develop an isothermal based multiplex recombinase polymerase amplification reaction (RPA), that can be integrated in the diagnostic workflow of endemic regions.

Methods

The RPA was designed targeting the Internal Transcribed Spacer (ITS) region to detect the presence of fungal DNA, and to differentiate between Madurella mycetomatis and Falciformispora senegalensis . The performance of the RPA was evaluated using 71 fungal isolates and five actinomycetes reference isolates. Furthermore, the limit of detection (LOD) was determined for the different probes in singleplex and multiplex.

Results

The ITS probe was positive for all 71 fungal isolates with a mean detection time of 13.1 min. The M. mycetomatis and F. senegalensis probes were only positive for their respective targets, with a mean detection time of 9.3 and 7.6 min, respectively. No cross-reactivity was detected, and a limit of detection of 0.01 ng of fungal DNA was found. The costs of the RPA ranged from €1.56 to €10.03, depending on the workflow.

Conclusion

We developed a field-friendly multiplex RPA, that successfully detects fungal DNA and discriminates between M. mycetomatis and F. senegalensis . This tool holds promise for enhancing diagnostic capabilities in eumycetoma endemic regions, paving the way for improved patient management and treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MycetomaMultiplex Polymerase Chain ReactionNucleic Acid Amplification TechniquesMolecular Diagnostic TechniquesHumansDNA, FungalSensitivity and SpecificityMadurellaRecombinasesDNA, Ribosomal SpacerLimit of Detection

Stichwörter der Autor:innen

Falciformispora senegalensisMadurella mycetomatisMycetomaRPApan-fungalpoint-of-care test

Substanzen

DNA, FungalRecombinasesDNA, Ribosomal Spacer

Autor:innen und Institutionen

  • Erasmus MC, Department of Medical Microbiology and Infectious Diseases, University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.
  • Faculty of Medical Laboratory Sciences, University of Khartoum, Kphartoum, Sudan.
  • Service de Parasitologie-Mycologie, UFR Sciences de la Santé, Université Gaston Berger, Saint-Louis, Senegal.
  • Mycetoma Research Center, University of Khartoum, Khartoum, Sudan.
  • Department of Internal medicine, UMC Utrecht, Utrecht, The Netherlands.
  • Erasmus MC, Department of Medical Microbiology and Infectious Diseases, University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands. w.vandesande@erasmusmc.nl.

Förderung

  • Diorapthe Foundation

Zitieren

APA

Konings, M., Siddig, E., Eadie, K., Minlekib, C. P., Faye, M., Sow, D., Fahal, A., Verbon, A., & van de Sande, W. (2025). The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma. European Journal of Clinical Microbiology & Infectious Diseases, 44(7), 1705-1714. https://doi.org/10.1007/s10096-025-05134-4

Vancouver

Konings M, Siddig E, Eadie K, Minlekib CP, Faye M, Sow D, et al. The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma. European Journal of Clinical Microbiology & Infectious Diseases. 2025;44(7):1705-1714. doi:10.1007/s10096-025-05134-4

BibTeX
@article{Konings2025,
  author = {Konings, Mickey and Siddig, Emmanuel and Eadie, Kimberly and Minlekib, Carole Pab and Faye, Maguette and Sow, Doudou and Fahal, Ahmed and Verbon, Annelies and van de Sande, Wendy},
  title = {The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2025},
  volume = {44},
  number = {7},
  pages = {1705--1714},
  doi = {10.1007/s10096-025-05134-4}
}
Kostenlos starten →